A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD) - Join Clinical Trial NCTNCT05562947
How to Join This Clinical Trial - NCTNCT05562947
Learn how to participate in this PHASE3 trial studying an investigational therapy for Neovascular Age-related Macular Degeneration, nAMD. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Neovascular Age-related Macular Degeneration, nAMD. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Neovascular Age-related Macular Degeneration, nAMD
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05562947 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 16 locations. Find a study site near you:
Clinical Research Site
Beijing City, 100032 - China
Status: RECRUITING
Clinical Research Site
Beijing, 100730 - China
Status: RECRUITING
Clinical Research Site
Beijing, 100730 - China
Status: RECRUITING
Clinical Research Site
Chengdu, 610041 - China
Status: RECRUITING
Clinical Research Site
Chengdu, 610072 - China
Status: RECRUITING
Clinical Research Site
Guangzhou City, 510060 - China
Status: RECRUITING
Clinical Research Site
Harbin, 150081 - China
Status: RECRUITING
Clinical Research Site
Qingdao City, 266109 - China
Status: RECRUITING
Clinical Research Site
Shanghai, 200080 - China
Status: RECRUITING
Clinical Research Site
Shanghai, 200092 - China
Status: RECRUITING
And 6 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE3 clinical trial for Neovascular Age-related Macular Degeneration, nAMD:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships